Microfluidics-based systems in diagnosis of Alzheimer's disease and biomimetic modeling

Yan Li, Danni Li, Pei Zhao, Krishnaswamy Nandakumar, Liqiu Wang*, Youqiang Song*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

18 Scopus citations


Early detection and accurate diagnosis of Alzheimer's disease (AD) is essential for patient care and disease treatment. Microfluidic technology is emerging as an economical and versatile platform in disease detection and diagnosis. It can be conveniently integrated with nanotechnology and/or biological models for biomedical functional and pre-clinical treatment study. These strengths make it advantageous in disease biomarker detection and functional analysis against a wide range of biological backgrounds. This review highlights the recent developments and trends of microfluidic applications in AD research. The first part looks at the principles and methods for AD diagnostic biomarker detection and profiling. The second part discusses how microfluidic chips, especially organ-on-a-chip platforms, could be used as an independent approach and/or integrated with other technologies in AD biomimetic functional analysis.

Original languageEnglish
Article number787
Issue number9
StatePublished - Sep 2020


  • AD biomarkers
  • Alzheimer's disease (AD)
  • Blood-brain barrier (BBB)
  • Microfluidic chips
  • Three-dimensional AD model


Dive into the research topics of 'Microfluidics-based systems in diagnosis of Alzheimer's disease and biomimetic modeling'. Together they form a unique fingerprint.

Cite this